Rivastigmine patch for treatment of Alzheimer's disease in clinical practice in Thailand
Background: Rivastigmine is a cholinesterase inhibitor for treatment of mild to moderate Alzheimer's disease (AD) and dementia associated with Parkinson's disease. The new patch formulation was recently made available. We assessed the safety, tolerability, and cognitive outcome of rivastig...
Saved in:
Main Authors: | Kongkiat Kulkantrakorn, Panas Tanyakitpisal, Somchai Towanabut, Charungthai Dejthevaporn, Poonsri Rangseekajee, Sunsanee Pongpakdee, Somsak Laptikultham, Kritsada Rodprasert, Suwanna Setthawatcharawanich, Bandit Thinkhamrop |
---|---|
Other Authors: | Faculty of Medicine, Thammasat University |
Format: | Article |
Published: |
2018
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/32475 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Efficacy and tolerability of rivastigmine patch therapy in patients with mild-to-moderate Alzheimer’s dementia associated with minimal and moderate ischemic white matter hyperintensities: A multicenter prospective open-label clinical trial
by: Park K.W., et al.
Published: (2019) -
A randomized controlled trial of rivastigmine in patients with cognitive impairment no dementia because of cerebrovascular disease
by: Narasimhalu, K., et al.
Published: (2014) -
Confirmation of the association between LRRK2 R1628P variant and susceptibility to Parkinson's disease in the Thai population
by: Teeratorn Pulkes, et al.
Published: (2018) -
Prevalence, clinical features and treatment outcomes of patients with myasthenia gravis positive for antibodies to muscle-specific kinase in Thailand
by: Rawiphan Witoonpanich, et al.
Published: (2018) -
Glucocerebrosidase mutations in Thai patients with Parkinson's disease
by: Teeratorn Pulkes, et al.
Published: (2018)